Elkfork Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Elkfork Partners’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$213K	Hold	4,396	–	–	0.01%	814
2019 Q2	$231K	Sell	4,396 -644	-13%	-$37K	0.01%	791
2019 Q1	$267K	Sell	5,040 -3,640	-42%	-$179K	0.01%	736
2018 Q4	$356K	Buy	+8,680	New	+$325K	0.01%	609
2018 Q3	–	Sell	-1,232	Closed	-$56K	–	1029
2018 Q2	$56K	Buy	+1,232	New	+$56.1K	﹤0.01%	971

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Elkfork Partners's GBT Position: Q3 2019 in Review

Elkfork Partners held its Global Blood Therapeutics, Inc. (GBT) position steady in Q3 2019 at 4,396 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #814.

Elkfork Partners first reported a position in GBT in Q2 2018 and has held it in 5 quarters since. The position peaked at $356K in Q4 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

Elkfork Partners held 4,396 shares of Global Blood Therapeutics, Inc. worth $213K as of Q3 2019.
Elkfork Partners left its Global Blood Therapeutics, Inc. share count unchanged in Q3 2019.
Global Blood Therapeutics, Inc. made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #814 holding.
Elkfork Partners first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and has held it in 5 quarters since.
Elkfork Partners's Global Blood Therapeutics, Inc. position peaked at $356K in Q4 2018.
208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.